Oral Manifestations of Human Immunodeficiency Virus Infection in High Risk Groups
Study Details
Study Description
Brief Summary
OBJECTIVES: I. Evaluate the development of oral manifestations of human immunodeficiency virus infection in relationship to the onset of immunologic alterations and systemic symptoms in different risk groups: gay/bisexual men, male intravenous drug users, and female intravenous drug users.
-
Evaluate the immune and inflammatory response to periodontal and other microbial pathogens.
-
Evaluate the bacterial species infecting the oral cavity in patients in these risk groups.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
PROTOCOL OUTLINE:
Patients undergo a periodontal assessment every 6 months until medically unable to continue. The oral/dental exam includes saliva and gingival crevicular fluid analysis and, as indicated, oral photographs.
Study Design
Outcome Measures
Primary Outcome Measures
Eligibility Criteria
Criteria
PROTOCOL ENTRY CRITERIA:
--Disease Characteristics-- Human immunodeficiency virus infection (HIV) seropositive or seronegative At risk for HIV, i.e.: Gay/bisexual men Male intravenous drug users Female intravenous drug users No acquired immunodeficiency syndrome Currently enrolled in Columbia Presbyterian Medical Center protocol "The Natural History and Progression of HIV Infection"
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- National Institute of Dental and Craniofacial Research (NIDCR)
- Columbia University
Investigators
- Study Chair: Ira B. Lamster, Columbia University
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 199/11861
- CU-SDOS-5059